SCHEMBL3847199

SCHEMBL3847199

CC(C)(C)n1ncc(S)c(Cl)c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 9/20 0.46
NPC1 O15118 4/20 0.46
KMT2A Q03164 4/20 0.46
RAB9A P51151 3/20 0.46
MEN1 O00255 3/20 0.46
LMNA P02545 2/20 0.46
GALR3 O60755 1/20 0.46
NR2F2 P24468 1/20 0.46
GPR183 P32249 1/20 0.46
GPR35 Q9HC97 1/20 0.46
HTT P42858 3/20 0.44
HPGD P15428 2/20 0.44
ATM Q13315 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43
TSHR P16473 7/20 0.37
MAPK1 P28482 4/20 0.37
CYP2C19 P33261 4/20 0.37
CYP3A4 P08684 3/20 0.37
CYP2C9 P11712 3/20 0.37
CYP2D6 P10635 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23188697 0.83 NPC1 (0.36) SMN1; SMN2NPC1KMT2ARAB9AMEN1
SCHEMBL1627210 0.81 SMN1; SMN2 (0.50) SMN1; SMN2NPC1KMT2ARAB9AMEN1
SCHEMBL9235153 0.79 SMN1; SMN2 (0.38) SMN1; SMN2NPC1KMT2ARAB9AMEN1
SCHEMBL17738012 0.79 SMN1; SMN2 (0.50) SMN1; SMN2NPC1KMT2ARAB9AMEN1
SCHEMBL27619400 0.78 SMN1; SMN2 (0.46) SMN1; SMN2NPC1KMT2ARAB9AMEN1
SCHEMBL11272569 0.78 SMN1; SMN2 (0.46) SMN1; SMN2NPC1KMT2ARAB9AMEN1
SCHEMBL9775182 0.78 PLA2G1B (0.38) SMN1; SMN2NPC1KMT2ARAB9AMEN1
SCHEMBL1627207 0.78 SMN1; SMN2 (0.46) SMN1; SMN2NPC1KMT2ARAB9AMEN1
SCHEMBL27671992 0.78 SMN1; SMN2 (0.44) SMN1; SMN2NPC1KMT2ARAB9AMEN1
SCHEMBL7016487 0.75 SMN1; SMN2 (0.51) SMN1; SMN2NPC1KMT2ARAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0239728-A2 Pyridazinone derivatives and the preparation thereof NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1987-10-07 EP claimed
EP-0134439-A1 Pyridazinone derivatives, preparation thereof and insecticidal, acaricidal, fungicidal compositions NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1985-03-20 EP claimed
JP-1313468-A None JP disclosed
JP-1197479-A None JP disclosed
JP-1180882-A None JP disclosed
JP-2045471-A None JP disclosed
CN-116262743-B Aryl-bi-ring-substituted pyridazinone compound and preparation method and application thereof 沈阳中化农药化工研发有限公司 2025-01-03 CN disclosed
CN-116262743-A Aryl-bi-ring-substituted pyridazinone compound and preparation method and application thereof 沈阳中化农药化工研发有限公司 2023-06-16 CN disclosed
CN-110396083-B Pyridazinonyl-contained butenolide compound and application thereof 沈阳中化农药化工研发有限公司 2022-05-06 CN disclosed
CN-112741095-B Application of pyridazinone isoxazole methyl sulfide compound as bactericide 沈阳中化农药化工研发有限公司 2022-01-11 CN disclosed
US-20210300878-A1 CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING LANTHEUS MEDICAL IMAGING, INC. (US) 2021-09-30 US disclosed
EP-0283271-A2 Pyridazinone derivative, process for producing thereof and insecticide, acaricide and fungicide containing said derivative as active ingredient UBE INDUSTRIES, LTD. (JP) 1988-09-21 EP disclosed
EP-0134439-B1 PYRIDAZINONE DERIVATIVES, PREPARATION THEREOF AND INSECTICIDAL, ACARICIDAL, FUNGICIDAL COMPOSITIONS NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1988-08-24 EP disclosed
EP-0239728-A3 Pyridazinone derivatives and the preparation thereof NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1988-01-20 EP disclosed
EP-0239728-A2 Pyridazinone derivatives and the preparation thereof NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1987-10-07 EP disclosed
EP-0239728-A2 Pyridazinone derivatives and the preparation thereof NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1987-10-07 EP disclosed
EP-0232825-A2 Pyridazinone derivatives, preparation thereof, and insecticidal, acaricidal, nematicidal, fungicidal compositions NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1987-08-19 EP disclosed
EP-0199281-A2 Pyridazinone derivatives, preparation thereof, and insecticidal, acaricidal, nematicidal, fungicidal compositions NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1986-10-29 EP disclosed
EP-0183212-A2 Pyridazinone derivatives, preparation thereof, and insecticidal, acaricidal, nematicidal, fungicidal compositions NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1986-06-04 EP disclosed
EP-0134439-A1 Pyridazinone derivatives, preparation thereof and insecticidal, acaricidal, fungicidal compositions NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1985-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300878-A1 CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING TNNI3, TNNT2, FABP3 SMN1; SMN2 2969/4885NPC1 350/4885KMT2A 4432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.